Androgens
SJR0.394
US

Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.394 | Q3 | 52.8% | |
| 2024 | — | — | 0.504 | Q2 | 62.5% | |
| 2023 | — | — | 0.419 | Q3 | 59.2% | |
| 2022 | — | — | 0.349 | Q3 | 55.3% | |
| 2021 | — | — | — | 10.8% | ||
| 2020 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2689-4653
country
coverage
2020-2022